Ledger.Open graph →
SEC Form D · filed January 2, 2024

BlossomHill Therapeutics, Inc

Offering
$100.0M
Sold
$88.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Hongbo Lu · Santa Clara, CADirectorCarl Gordon · CAMBRIDGE, MADirectorYishan Li · San Diego, CAExec · DirectorCarl Gordon · SAN FRANCISCO, CADirectorBihua Chen · San Diego, CADirectorHongbo Lu · Waltham, MADirectorJingrong Jean Cui · San Diego, CAExec · DirectorGeorge Lee · Fremont, CADirectorBihua Chen · San Diego, CADirectorYishan Li · San Diego, CAExec · DirectorSundeep Agrawal · San Diego, CADirectorSundeep Agrawal · San Diego, CADirectorJingrong Jean Cui · San Diego, CAExec · DirectorCarl Gordon · Encinitas, CADirectorGeorge Lee · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗